Doctor profile · Federal record
Dr. Charles Meyers, M.D.
Dermatology Physician (CMS: Dermatology) · Exton, PA
- NPI 1225097769
- Accepts Medicare
- MIPS 77.1 / 100 · 2023
- 25 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
501 Gordon Dr
Exton, PA 193411252
(610) 594-6660
fax (610) 594-6810
Credentials & registration
- NPI registered
- March 2006 — 20 yrs on file
- Profile last updated
- May 14, 2008
- Year of graduation
- 2001 — 25 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State license (1)
- Pennsylvania #MD425728
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1225097769. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
10,501
Distinct HCPCS
10
Medicare allowed
$577,688
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 4,346 | 712 | $7 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 2,184 | 1,497 | $94 | |
17000 |
Destruction of precancer skin growth, 1 growth | 1,411 | 962 | $55 | |
11102 |
Biopsy of related skin growth, first growth | 659 | 527 | $95 | |
17110 |
Destruction of skin growth, 1-14 growths | 626 | 527 | $118 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 242 | 215 | $59 | |
11103 |
Biopsy of related skin growth, each additional growth | 221 | 138 | $53 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 176 | 176 | $116 | |
17262 |
Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | 113 | 98 | $176 | |
17004 |
Destruction of precancer skin growth, 15 or more growths | 66 | 52 | $179 |
In context: peer comparison
Among 1 peers in this city , average services per provider: 420. This provider delivers 25× the peer median.Open Payments
Industry payments received
All-time total
$1,696
Transactions
85
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Janssen Biotech, Inc. | 15 | $395.74 | |
| ABBVIE INC. | 25 | $338.01 | |
| Regeneron Healthcare Solutions, Inc. | 4 | $148.30 | |
| Incyte Corporation | 5 | $126.77 | |
| UCB, Inc. | 6 | $119.78 | |
| E.R. Squibb & Sons, L.L.C. | 7 | $115.95 | |
| LEO Pharma Inc. | 5 | $93.65 | |
| Lilly USA, LLC | 5 | $81.42 | |
| GENZYME CORPORATION | 3 | $68.97 | |
| Amgen Inc. | 3 | $56.13 | |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $35.48 | |
| Dermavant Sciences, Inc. | 2 | $30.06 | |
| Organogenesis Inc. | 1 | $25.47 | |
| PFIZER INC. | 1 | $24.90 | |
| Novartis Pharmaceuticals Corporation | 1 | $20.44 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
771
Patients
536
Total drug cost
$125,491
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Triamcinolone Acetonide | Generic | 195 | 153 | $2,166 |
| Ketoconazole | Generic | 129 | 79 | $3,698 |
| Clobetasol Propionate | Generic | 80 | 53 | $3,886 |
| Mupirocin | Generic | 80 | 75 | $660 |
| Doxycycline Hyclate | Generic | 44 | 28 | $2,170 |
| Fluorouracil | Generic | 38 | 37 | $3,522 |
| Hydrocortisone | Generic | 36 | 34 | $212 |
| Metronidazole | Generic | 31 | 21 | $2,199 |
| Dupixent Syringe (Dupilumab) | Brand | 28 | 0 | $103,444 |
| Betamethasone Dipropionate | Generic | 23 | 0 | $1,285 |
Frequently asked questions
What is Dr. Charles Meyers's medical specialty?
Dr. Charles Meyers practices Dermatology Physician in Exton, PA.
Where does Dr. Charles Meyers practice?
Dr. Charles Meyers practices at 501 Gordon Dr, Exton, PA 193411252. Office phone: 6105946660.
What is Dr. Charles Meyers's NPI?
Dr. Charles Meyers's National Provider Identifier (NPI) is 1225097769, issued by NPPES.
Does Dr. Charles Meyers accept Medicare assignment?
Yes. Dr. Charles Meyers accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Charles Meyers commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.